2-oxoglutarate dehydrogenase complex component E2, Dihydrolipoamide S succinyltransferase (E2 component of 2 oxo glutarate complex), Dihydrolipoamide S succinyltransferase, Dihydrolipoamide succinyltransferase component of 2 oxoglutarate dehydrogenase complex, Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex, Dihydrolipoyllysine residue succinyltransferase component of 2 oxoglutarate dehydrogenase complex mitochondrial, Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, Dlst, DLTS, E2, E2K, mitochondrial, ODO2_HUMAN, OGDC-E2.
The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO2. The complex contains multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3). DLST (dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial), also known as DLTS or 2-oxoglutarate dehydrogenase complex component E2, is a 453 amino acid protein belonging to the 2-oxoacid dehydrogenase family. DLST covalently binds one lipoyl cofactor and participates in L-lysine degradation via the saccharopine pathway. Localized to the mitochondrion, DLST forms a 24-polypeptide structural core with octahedral symmetry. The gene encoding DLST maps to human chromosome 14q24.3 and mouse chromosome 12 D2.
